Gracell Biotechnologies Inc. (GRCL) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 3 Buy, 5 Hold.
The consensus price target is $6.00, representing a downside of 41.5% from the current price $10.25.
GRCL Stock — 12-Month Price Forecast
$6.00
▼ -41.46% Downside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for Gracell Biotechnologies Inc., the price target is $6.00.
The average price target represents a -41.46% change from the last price of $10.25.
GRCL Analyst Ratings
Hold
Based on 8 analysts giving stock ratings to Gracell Biotechnologies Inc. in the past 3 months
